Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
paradigm_report_works_22122023
10.1016_j.ejphar.2020.172914
21
2020
172914
172914
article
871
European Journal of Pharmacology
Elsevier BV
Cynthia Kwan
Imane Frouni
Dominique Bédard
Adjia Hamadjida
Philippe Huot
False
10.1016/j.ejphar.2020.172914
Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our
Terms of Service and Privacy Policy.